Skip to main content
. 2019 Jan 24;12:103–108. doi: 10.2147/CCID.S186621

Figure 2.

Figure 2

Standard and erythema-directed digital photography with VISIA-CR of a patient with moderate facial seborrheic dermatitis showing a significant reduction (P<0.001) in erythema at 15 days (erythema score: 2, B1B2), 30 days (erythema score: 1, C1C2), and 60 days (erythema score: 0, D1D2) compared to baseline (erythema score: 3, A1A2).

Notes: Erythema scale: 4 = severe erythema; 3 = moderate erythema; 2 = mild erythema; 1 = very mild erythema; 0 = no erythema.